Datasets:
stanpony
/
fine_tune_patient_diagnoses

Dataset card Data Studio Files Community
1
patient_nbr
int64
135
190M
Patient context and readmission decision formatted for training
stringlengths
1.99k
2.15k
44,193,978
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): 785. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
41,777,019
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 38. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 15. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
86,724,999
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 32. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 444. The secondary diagnosis (coded as first three digits of ICD9): 203. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
92,235,492
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 965. The secondary diagnosis (coded as first three digits of ICD9): 518. Additional secondary diagnosis (coded as first three digits of ICD9): 493. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
168,496,466
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 995. The secondary diagnosis (coded as first three digits of ICD9): 518. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
36,948,033
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 780. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
59,296,194
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 38. The secondary diagnosis (coded as first three digits of ICD9): 584. Additional secondary diagnosis (coded as first three digits of ICD9): 262. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
91,167,804
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 263. The secondary diagnosis (coded as first three digits of ICD9): 196. Additional secondary diagnosis (coded as first three digits of ICD9): 174. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: Steady. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
111,190,977
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: nan. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 530. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
48,394,971
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 283. Additional secondary diagnosis (coded as first three digits of ICD9): 220. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
94,120,866
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Expired at home. Medicaid only, hospice.. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: UN. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 423. The secondary diagnosis (coded as first three digits of ICD9): 997. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
84,752,001
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 11. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
86,450,409
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 590. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 600. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
120,984,278
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Hispanic. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.8. The secondary diagnosis (coded as first three digits of ICD9): 998. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
38,936,025
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 724. The secondary diagnosis (coded as first three digits of ICD9): 572. Additional secondary diagnosis (coded as first three digits of ICD9): 571. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
38,683,539
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
131,369,585
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
60,766,254
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: nan. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 85. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 50. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
118,019,255
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 202. Additional secondary diagnosis (coded as first three digits of ICD9): 204. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
180,739,895
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: CM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 32. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 518. The secondary diagnosis (coded as first three digits of ICD9): 491. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
141,409,661
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Transfer from another health care facility. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 290. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
76,967,820
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 38. The secondary diagnosis (coded as first three digits of ICD9): 482. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
41,456,052
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MD. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
94,077,981
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: MC. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 28. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 2. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 998. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 8. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
39,853,602
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
126,546,161
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 824. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 719. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
150,808,820
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 435. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 438. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
51,672,447
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): [50-75). admission type: Emergency. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Transfer from another health care facility. Number of days between admission and discharge: 7. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 2. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 707. The secondary diagnosis (coded as first three digits of ICD9): 682. Additional secondary diagnosis (coded as first three digits of ICD9): 294. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
52,790,427
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
22,876,245
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: nan. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 558. The secondary diagnosis (coded as first three digits of ICD9): 577. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
141,423,152
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 327. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
55,607,031
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 458. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
105,327,927
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Transfer from a Skilled Nursing Facility (SNF). Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 10. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 8. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
89,910,360
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: MD. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 3. Number of inpatient visits of the patient in the year preceding the encounter: 4. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 197. Additional secondary diagnosis (coded as first three digits of ICD9): 304. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
138,920,540
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 250.82. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 296. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
184,591,094
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 2. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 730. The secondary diagnosis (coded as first three digits of ICD9): 250.8. Additional secondary diagnosis (coded as first three digits of ICD9): 731. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
38,670,570
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: MD. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 4. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 536. Additional secondary diagnosis (coded as first three digits of ICD9): 724. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
43,806,933
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 21. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 661. The secondary diagnosis (coded as first three digits of ICD9): 648. Additional secondary diagnosis (coded as first three digits of ICD9): 659. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
32,218,515
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 32. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 2. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 203. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
126,346,019
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MD. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 786. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
42,666,696
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: CM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 29. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 530. Additional secondary diagnosis (coded as first three digits of ICD9): 786. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
186,400,166
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 592. The secondary diagnosis (coded as first three digits of ICD9): 423. Additional secondary diagnosis (coded as first three digits of ICD9): 332. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
71,489,691
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: MC. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 581. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 515. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
40,711,671
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 786. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Up. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
42,651,189
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 3. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
98,449,092
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: SP. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: Steady. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
88,785,891
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: Elective. discharge disposition: Left AMA. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: OG. Medical speciality of the admitting physician: Psychology. Number of lab tests performed during the encounter: 9. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 3. Number of inpatient visits of the patient in the year preceding the encounter: 9. The primary diagnosis (coded as first three digits of ICD9): 296. The secondary diagnosis (coded as first three digits of ICD9): 305. Additional secondary diagnosis (coded as first three digits of ICD9): 292. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
125,286,431
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 20. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 493. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
48,264,381
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Asian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 3. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 998. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
91,675,926
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 401. The secondary diagnosis (coded as first three digits of ICD9): 997. Additional secondary diagnosis (coded as first three digits of ICD9): 560. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
143,785,463
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 434. Additional secondary diagnosis (coded as first three digits of ICD9): 584. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
65,212,713
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): [50-75). admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: DM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 2. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
117,496,841
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): [75-100). admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: CM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 745. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
94,815,090
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
40,727,115
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 558. The secondary diagnosis (coded as first three digits of ICD9): 38. Additional secondary diagnosis (coded as first three digits of ICD9): 995. Number of diagnosis: 13. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: Down. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>
98,660,178
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Asian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: UN. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 10. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 435. The secondary diagnosis (coded as first three digits of ICD9): 362. Additional secondary diagnosis (coded as first three digits of ICD9): 729. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
88,647,516
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 3. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
106,174,269
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 11. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 403. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
153,319,217
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.12. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
180,325,049
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 415. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
160,374,038
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 486. Additional secondary diagnosis (coded as first three digits of ICD9): 493. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
179,012,084
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: CM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 577. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
110,877,237
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: SP. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 574. The secondary diagnosis (coded as first three digits of ICD9): 577. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
49,015,377
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 401. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 536. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
41,098,491
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 285. The secondary diagnosis (coded as first three digits of ICD9): 578. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
155,001,839
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Asian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Nephrology. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 780. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): 425. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
86,919,651
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
38,897,721
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 491. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
38,650,932
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 746. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
105,432,939
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 491. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
35,714,475
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: CM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 26. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 799. Additional secondary diagnosis (coded as first three digits of ICD9): 530. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
108,070,092
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 31. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 266. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: >200. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
42,654,456
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: SP. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 518. The secondary diagnosis (coded as first three digits of ICD9): 516. Additional secondary diagnosis (coded as first three digits of ICD9): 516. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
41,311,449
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 298. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
45,814,248
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: SP. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
114,713,712
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: MD. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 74. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 29. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 5. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 596. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 560. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
102,317,688
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 680. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 110. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
138,862,238
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: SP. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 560. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
123,063,440
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 26. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 789. The secondary diagnosis (coded as first three digits of ICD9): 786. Additional secondary diagnosis (coded as first three digits of ICD9): 492. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
134,738,807
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Asian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 74. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 584. Additional secondary diagnosis (coded as first three digits of ICD9): 585. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
41,761,152
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 7. Payer code: DM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 18. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 620. The secondary diagnosis (coded as first three digits of ICD9): 614. Additional secondary diagnosis (coded as first three digits of ICD9): 788. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
39,973,257
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 695. The secondary diagnosis (coded as first three digits of ICD9): 493. Additional secondary diagnosis (coded as first three digits of ICD9): 601. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
85,206,699
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: BC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 575. The secondary diagnosis (coded as first three digits of ICD9): V85. Additional secondary diagnosis (coded as first three digits of ICD9): 250.4. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
90,489,195
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MD. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 29. Number of inpatient visits of the patient in the year preceding the encounter: 7. The primary diagnosis (coded as first three digits of ICD9): 780. The secondary diagnosis (coded as first three digits of ICD9): 305. Additional secondary diagnosis (coded as first three digits of ICD9): 244. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
184,013,600
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 5. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 357. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
38,584,836
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: CH. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 22. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 3. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 285. The secondary diagnosis (coded as first three digits of ICD9): 238. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>
41,172,399
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: CP. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 38. The secondary diagnosis (coded as first three digits of ICD9): 584. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
141,453,482
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 335. Additional secondary diagnosis (coded as first three digits of ICD9): E932. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
33,942,636
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Asian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: MD. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
42,839,874
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MD. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 295. The secondary diagnosis (coded as first three digits of ICD9): V62. Additional secondary diagnosis (coded as first three digits of ICD9): 298. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
89,012,745
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: nan. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 782. The secondary diagnosis (coded as first three digits of ICD9): V85. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
109,867,950
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 300. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
161,136,248
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: BC. Medical speciality of the admitting physician: Hospitalist. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 41. Additional secondary diagnosis (coded as first three digits of ICD9): V85. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
90,092,583
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another rehab fac including rehab units of a hospital .. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: MC. Medical speciality of the admitting physician: Emergency/Trauma. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 820. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s>
86,308,479
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: HM. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>
32,559,120
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: MC. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 85. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 37. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 789. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 285. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
30,272,031
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Hispanic. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: MD. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 571. The secondary diagnosis (coded as first three digits of ICD9): 250.22. Additional secondary diagnosis (coded as first three digits of ICD9): 572. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
46,029,384
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: MC. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.02. The secondary diagnosis (coded as first three digits of ICD9): 584. Additional secondary diagnosis (coded as first three digits of ICD9): 518. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>
141,558,035
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: CM. Medical speciality of the admitting physician: Radiologist. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 40. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 511. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: Steady. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>
65,953,620
<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: MC. Medical speciality of the admitting physician: Radiologist. Number of lab tests performed during the encounter: 1. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>